£72.61

Drug Resistant Neoplasms (Cancer Etiology Diagnosis and Treatment Series)

Price data last checked 16 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

About as cheap as it gets. The only time it was cheaper was 2 months ago.

£73 today · all-time low £70 (May 2026) · usually £74

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 75 days · 75 data points (no recent data)

Historical
Generating forecast…
£73.74 £69.13 £70.14 £71.14 £72.15 £73.15 £74.16 25 April 2026 13 May 2026 01 June 2026 19 June 2026 08 July 2026

Price Distribution

Price distribution over 75 days • 4 price levels

Days at Price
Current Price
17 days 23 days 22 days · current 13 days 0 6 12 17 23 £70 £71 £73 £74 Days at Price

Price Analysis

Most common price: £71 (23 days, 30.7%)

Price range: £70 - £74

Price levels: 4 different prices over 75 days

Description

One of the main causes of failure in the treatment of cancer is the development of drug resistance by the cancer cells. The design of cancer chemotherapy has become increasingly sophisticated, yet there is no cancer treatment that is 100% effective against disseminated cancer. Resistance to treatment with anticancer drugs results from a variety of factors including individual variations in patients and somatic cell genetic differences in tumours, even those from the same tissue of origin. Frequently, resistance is intrinsic to the cancer, but as therapy becomes more and more effective, acquired resistance has also become common. The most common reason for acquisition of resistance to a broad range of anticancer drugs is expression of one or more energy-dependent transporters that detect and eject anticancer drugs from cells. Studies on the mechanisms of cancer drug resistance have yielded important information about how to circumvent this resistance to improve cancer chemotherapy and its implications for pharmacokinetics of many commonly used drugs. This book presents new and important research in this field.

Key Features

New

Mint Condition

Dispatch same day for order received before 12 noon

Guaranteed packaging

No quibbles returns

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
29 March 2010
Listed Since
06 June 2009

Barcode

No barcode data available

Similar Products You Might Like

Progress in Cancer Drug Resistance Research
98% match

Progress in Cancer Drug Resistance Research

£100.09 09 Jul 2026
Biological Mechanisms and the Advancing Approaches to Overcoming Cancer Drug Resistance (Volume 12) (Cancer Sensitizing Agents for Chemotherapy, Volume 12)
97% match

Biological Mechanisms and the Advancing Approaches to Overcoming Cancer Drug Resistance (Volume 12) (Cancer Sensitizing Agents for Chemotherapy, Volume 12)

Academic Press

£119.29 16 Jun 2026
Drug Resistance in Cancer: Mechanisms and Models
97% match

Drug Resistance in Cancer: Mechanisms and Models

Cambridge University Press

£104.76 12 Jun 2026
Cancer Drug Resistance (Cancer Drug Discovery and Development)
97% match

Cancer Drug Resistance (Cancer Drug Discovery and Development)

Humana

£32.12 16 Jun 2026
Multiple Drug Resistance in Cancer 2: Molecular, Cellular and Clinical Aspects
97% match

Multiple Drug Resistance in Cancer 2: Molecular, Cellular and Clinical Aspects

Springer

£149.84 24 Jul 2026
Drug Resistance in Oncology: 13 (Basic and Clinical Oncology)
97% match

Drug Resistance in Oncology: 13 (Basic and Clinical Oncology)

CRC Press

£35.69 12 May 2026
Anticancer Drug Resistance: Advances in Molecular and Clinical Research: 73 (Cancer Treatment and Research, 73)
97% match

Anticancer Drug Resistance: Advances in Molecular and Clinical Research: 73 (Cancer Treatment and Research, 73)

Springer

£146.42 14 Jul 2026
Multiple Drug Resistance in Cancer 2: Molecular, Cellular and Clinical Aspects
97% match

Multiple Drug Resistance in Cancer 2: Molecular, Cellular and Clinical Aspects

Springer

£165.11 18 Jul 2026
Wiley-Blackwell Multidrug Resistance in Cancer Cells Book
97% match

Wiley-Blackwell Multidrug Resistance in Cancer Cells Book

Wiley-Blackwell

£128.72 16 May 2026
Cancer Drug Resistance (Cancer Drug Discovery and Development)
97% match

Cancer Drug Resistance (Cancer Drug Discovery and Development)

Humana

£154.49 16 Jun 2026
Cancer Drug Resistance: Overviews and Methods: 1395 (Methods in Molecular Biology, 1395)
96% match

Cancer Drug Resistance: Overviews and Methods: 1395 (Methods in Molecular Biology, 1395)

Humana

£88.19 03 Jul 2026
Cancer Cell Chemoresistance And Chemosensitization
96% match

Cancer Cell Chemoresistance And Chemosensitization

Scientific Publishing

£148.00 10 Jul 2026
Molecular Oncology: Underlying Mechanisms and Translational Advancements
96% match

Molecular Oncology: Underlying Mechanisms and Translational Advancements

Springer

£86.56 09 Jul 2026
Multiple Drug Resistance in Cancer: Cellular, Molecular and Clinical Approaches: v. 1
96% match

Multiple Drug Resistance in Cancer: Cellular, Molecular and Clinical Approaches: v. 1

Springer

£184.00 14 Jun 2026
Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)
96% match

Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)

Springer

£149.64 16 Jun 2026
Drug Repurposing in Cancer Therapy: Approaches and Applications
96% match

Drug Repurposing in Cancer Therapy: Approaches and Applications

Academic Press

£135.65 13 Jun 2026
Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)
96% match

Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)

Springer

£166.09 13 Jul 2026
Wiley Anticancer Therapeutics - Oncology Drug Design Book
96% match

Wiley Anticancer Therapeutics - Oncology Drug Design Book

Wiley

£133.39 15 Jul 2026
Springer - Molecular Mechanisms of Tumor Cell Resistance
96% match

Springer - Molecular Mechanisms of Tumor Cell Resistance

Springer

£96.38 16 Jul 2026
Drug Resistance in Cancer Cells
96% match

Drug Resistance in Cancer Cells

Springer

£108.00 13 Jul 2026
New Trends in the Molecular and Biological Basis for Clinical Oncology
96% match

New Trends in the Molecular and Biological Basis for Clinical Oncology

Springer

£77.87 04 Jul 2026
Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways: 15 (Resistance to Targeted Anti-Cancer Therapeutics, 15)
96% match

Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways: 15 (Resistance to Targeted Anti-Cancer Therapeutics, 15)

Springer

£107.85 17 Jul 2026
Springer - Drug Resistance in Leukemia and Lymphoma III
95% match

Springer - Drug Resistance in Leukemia and Lymphoma III

Springer

£148.31 08 Jul 2026
Drug Resistance in Leukemia and Lymphoma III: 457 (Advances in Experimental Medicine and Biology, 457)
95% match

Drug Resistance in Leukemia and Lymphoma III: 457 (Advances in Experimental Medicine and Biology, 457)

Springer

£172.55 17 Jun 2026